KR100863239B1 - 신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는t-형 칼슘 채널 저해제 - Google Patents
신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는t-형 칼슘 채널 저해제 Download PDFInfo
- Publication number
- KR100863239B1 KR100863239B1 KR1020070050185A KR20070050185A KR100863239B1 KR 100863239 B1 KR100863239 B1 KR 100863239B1 KR 1020070050185 A KR1020070050185 A KR 1020070050185A KR 20070050185 A KR20070050185 A KR 20070050185A KR 100863239 B1 KR100863239 B1 KR 100863239B1
- Authority
- KR
- South Korea
- Prior art keywords
- arh
- thiazolidin
- nmr
- yield
- cyclohexyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000003691 T-Type Calcium Channels Human genes 0.000 title abstract description 44
- 108090000030 T-Type Calcium Channels Proteins 0.000 title abstract description 44
- CQOALHPQGSYSNO-UHFFFAOYSA-N 5h-1,3-thiazol-2-imine Chemical class N=C1SCC=N1 CQOALHPQGSYSNO-UHFFFAOYSA-N 0.000 title abstract description 11
- 239000003112 inhibitor Substances 0.000 title description 7
- -1 trifluoromethoxy, phenyloxy, amino Chemical group 0.000 claims abstract description 154
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims abstract description 91
- 150000001875 compounds Chemical class 0.000 claims abstract description 60
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 15
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 15
- 125000005843 halogen group Chemical group 0.000 claims abstract description 12
- 206010002383 Angina Pectoris Diseases 0.000 claims abstract description 9
- 206010020772 Hypertension Diseases 0.000 claims abstract description 9
- 208000002193 Pain Diseases 0.000 claims abstract description 9
- 206010015037 epilepsy Diseases 0.000 claims abstract description 9
- 201000010099 disease Diseases 0.000 claims abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 8
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 6
- 201000011510 cancer Diseases 0.000 claims abstract description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 6
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims abstract description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 5
- 206010003119 arrhythmia Diseases 0.000 claims abstract description 4
- 230000006793 arrhythmia Effects 0.000 claims abstract description 4
- 239000000460 chlorine Substances 0.000 claims description 355
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 202
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 47
- 229910052739 hydrogen Inorganic materials 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 29
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 13
- 238000010992 reflux Methods 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 125000003670 adamantan-2-yl group Chemical group [H]C1([H])C(C2([H])[H])([H])C([H])([H])C3([H])C([*])([H])C1([H])C([H])([H])C2([H])C3([H])[H] 0.000 claims description 4
- 125000004966 cyanoalkyl group Chemical group 0.000 claims description 4
- 150000002431 hydrogen Chemical class 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 13
- 230000002401 inhibitory effect Effects 0.000 abstract description 11
- 230000002018 overexpression Effects 0.000 abstract description 5
- 229940124597 therapeutic agent Drugs 0.000 abstract description 4
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000002844 melting Methods 0.000 description 391
- 230000008018 melting Effects 0.000 description 391
- 229920002554 vinyl polymer Polymers 0.000 description 147
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 135
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 24
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- 239000011541 reaction mixture Substances 0.000 description 13
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 10
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 239000007995 HEPES buffer Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- DKNDOKIVCXTFHJ-HNNXBMFYSA-N 3,5-dichloro-n-[[1-[[(4s)-2,2-dimethyloxan-4-yl]methyl]-4-fluoropiperidin-4-yl]methyl]benzamide Chemical compound C1COC(C)(C)C[C@H]1CN1CCC(F)(CNC(=O)C=2C=C(Cl)C=C(Cl)C=2)CC1 DKNDOKIVCXTFHJ-HNNXBMFYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 102000003922 Calcium Channels Human genes 0.000 description 5
- 108090000312 Calcium Channels Proteins 0.000 description 5
- 108091006146 Channels Proteins 0.000 description 5
- FRELJZKRMHYIQQ-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 FRELJZKRMHYIQQ-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 208000031229 Cardiomyopathies Diseases 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 3
- 208000021908 Myocardial disease Diseases 0.000 description 3
- 208000012902 Nervous system disease Diseases 0.000 description 3
- 208000025966 Neurological disease Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000009401 metastasis Effects 0.000 description 3
- 238000011445 neoadjuvant hormone therapy Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 208000019553 vascular disease Diseases 0.000 description 3
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 2
- UBJPBILZJQMLFW-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2,5-difluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC(F)=CC=C1F UBJPBILZJQMLFW-UHFFFAOYSA-N 0.000 description 2
- CRVGWTXVAGAZRA-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCCC1 CRVGWTXVAGAZRA-UHFFFAOYSA-N 0.000 description 2
- OASJPKCRMUXPTE-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCC1 OASJPKCRMUXPTE-UHFFFAOYSA-N 0.000 description 2
- ZQCMYBXDGSJIJP-UHFFFAOYSA-N 2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 ZQCMYBXDGSJIJP-UHFFFAOYSA-N 0.000 description 2
- BQDXNRTYSBHSTE-UHFFFAOYSA-N 2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 BQDXNRTYSBHSTE-UHFFFAOYSA-N 0.000 description 2
- VVRZOYXBUBDOBI-UHFFFAOYSA-N 2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C=1C=C(OC=2C=CC=CC=2)C=CC=1NC(=O)CC(N1C2CCCCC2)CSC1=NC1CCCCC1 VVRZOYXBUBDOBI-UHFFFAOYSA-N 0.000 description 2
- JCIRGLIHPQYIBK-UHFFFAOYSA-N 2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(C(F)(F)F)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 JCIRGLIHPQYIBK-UHFFFAOYSA-N 0.000 description 2
- IORZURBBCYAHPK-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-ethyl-1,3-thiazolidin-4-yl]-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CC)C1CC(=O)NC1=CC=C(CC)C=C1 IORZURBBCYAHPK-UHFFFAOYSA-N 0.000 description 2
- ZIYLACLIGKJTJP-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC1=CC=C(F)C=C1 ZIYLACLIGKJTJP-UHFFFAOYSA-N 0.000 description 2
- QJDFOTXUYCWFQZ-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-(4-methylphenyl)-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C=CC(C)=CC=2)CSC1=NC1CCCCCC1 QJDFOTXUYCWFQZ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- HBNPJJILLOYFJU-VMPREFPWSA-N Mibefradil Chemical group C1CC2=CC(F)=CC=C2[C@H](C(C)C)[C@@]1(OC(=O)COC)CCN(C)CCCC1=NC2=CC=CC=C2N1 HBNPJJILLOYFJU-VMPREFPWSA-N 0.000 description 2
- CHAQNIVEZJMNCV-UHFFFAOYSA-N N-[3,5-bis(trifluoromethyl)phenyl]-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)CSC1=NC1CCCCCC1 CHAQNIVEZJMNCV-UHFFFAOYSA-N 0.000 description 2
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 2
- 206010038389 Renal cancer Diseases 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229960004438 mibefradil Drugs 0.000 description 2
- IOZSQFKAIOPLLL-UHFFFAOYSA-N n-(4-bromophenyl)-2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(Br)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 IOZSQFKAIOPLLL-UHFFFAOYSA-N 0.000 description 2
- ANPKZESOZDFKLU-UHFFFAOYSA-N n-(4-butylphenyl)-2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 ANPKZESOZDFKLU-UHFFFAOYSA-N 0.000 description 2
- ZOTABBUHMBXXDZ-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 ZOTABBUHMBXXDZ-UHFFFAOYSA-N 0.000 description 2
- CYEYUUDSUOCJHZ-UHFFFAOYSA-N n-[3,5-bis(trifluoromethyl)phenyl]-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 CYEYUUDSUOCJHZ-UHFFFAOYSA-N 0.000 description 2
- XZZQYSFDFWEPRR-UHFFFAOYSA-N n-[3,5-bis(trifluoromethyl)phenyl]-2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC(C(F)(F)F)=CC(NC(=O)CC2N(C(=NC3CCCCC3)SC2)C2CCCCC2)=C1 XZZQYSFDFWEPRR-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 201000010174 renal carcinoma Diseases 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 201000011531 vascular cancer Diseases 0.000 description 2
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- NIMLVCYPYQJARV-UHFFFAOYSA-N 1-(1-adamantyl)-1-propylthiourea Chemical compound C1C(C2)CC3CC2CC1(N(C(N)=S)CCC)C3 NIMLVCYPYQJARV-UHFFFAOYSA-N 0.000 description 1
- MKVIIOWMZOUIBE-UHFFFAOYSA-N 1-adamantylmethylurea Chemical compound C1C(C2)CC3CC2CC1(CNC(=O)N)C3 MKVIIOWMZOUIBE-UHFFFAOYSA-N 0.000 description 1
- JMBFGXRDSBYXGJ-UHFFFAOYSA-N 2-(1-adamantyl)ethylurea Chemical compound C1C(C2)CC3CC2CC1(CCNC(=O)N)C3 JMBFGXRDSBYXGJ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- DRFWPRBCXGDYMK-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C(=CC=C(C=2)[N+]([O-])=O)F)C(C)SC1=NC1CCCCCC1 DRFWPRBCXGDYMK-UHFFFAOYSA-N 0.000 description 1
- JCICTGHCUAVLPE-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C(=CC=CC=2)F)C(C)SC1=NC1CCCCCC1 JCICTGHCUAVLPE-UHFFFAOYSA-N 0.000 description 1
- SEJDDPWFLOOEPM-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=C(Cl)C=C(Cl)C=2)C(C)SC1=NC1CCCCCC1 SEJDDPWFLOOEPM-UHFFFAOYSA-N 0.000 description 1
- AKRWNBXGQONYCR-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(3-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=C(F)C=CC=2)C(C)SC1=NC1CCCCCC1 AKRWNBXGQONYCR-UHFFFAOYSA-N 0.000 description 1
- UIOCLAZPIIXWNR-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(C(C)S1)N(C)C1=NC1CCCCCC1 UIOCLAZPIIXWNR-UHFFFAOYSA-N 0.000 description 1
- QBPVWXFPCIIURJ-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(F)=CC=2)C(C)SC1=NC1CCCCCC1 QBPVWXFPCIIURJ-UHFFFAOYSA-N 0.000 description 1
- YQJDRCVBMFHXCG-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1NC(=O)CC(C(C)S1)N(C)C1=NC1CCCCCC1 YQJDRCVBMFHXCG-UHFFFAOYSA-N 0.000 description 1
- PUNRCNSQYCZSEU-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(C)=CC=2)C(C)SC1=NC1CCCCCC1 PUNRCNSQYCZSEU-UHFFFAOYSA-N 0.000 description 1
- LIDWNVKABFQTOH-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(=CC=2)[N+]([O-])=O)C(C)SC1=NC1CCCCCC1 LIDWNVKABFQTOH-UHFFFAOYSA-N 0.000 description 1
- MVJOXJKNMJVNPQ-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(C(C)S1)N(C)C1=NC1CCCCCC1 MVJOXJKNMJVNPQ-UHFFFAOYSA-N 0.000 description 1
- ITIMHULENFPWSQ-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-[4-(trifluoromethoxy)phenyl]acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(OC(F)(F)F)=CC=2)C(C)SC1=NC1CCCCCC1 ITIMHULENFPWSQ-UHFFFAOYSA-N 0.000 description 1
- SFDKEYOZYXMQGG-UHFFFAOYSA-N 2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-phenylacetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC=CC=2)C(C)SC1=NC1CCCCCC1 SFDKEYOZYXMQGG-UHFFFAOYSA-N 0.000 description 1
- XMZSPYRIDYPAEC-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2,4-difluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1F XMZSPYRIDYPAEC-UHFFFAOYSA-N 0.000 description 1
- WXUKYIYNMQQGAT-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(C)C=C1F WXUKYIYNMQQGAT-UHFFFAOYSA-N 0.000 description 1
- UPPXPHMCYICQRT-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F UPPXPHMCYICQRT-UHFFFAOYSA-N 0.000 description 1
- HKSGGNPGXYWEGE-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCCCC1 HKSGGNPGXYWEGE-UHFFFAOYSA-N 0.000 description 1
- OVKKYBOAFQMJDW-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1 OVKKYBOAFQMJDW-UHFFFAOYSA-N 0.000 description 1
- LUFRVNYIAZWADV-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-methoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCCCC1 LUFRVNYIAZWADV-UHFFFAOYSA-N 0.000 description 1
- DYSCPIMOASHPLK-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C([N+]([O-])=O)C=C1 DYSCPIMOASHPLK-UHFFFAOYSA-N 0.000 description 1
- QZYCEFAYFSLELS-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCCCC1 QZYCEFAYFSLELS-UHFFFAOYSA-N 0.000 description 1
- ZDGDBDPZXCVEOY-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(4-fluorophenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NCC1=CC=C(F)C=C1 ZDGDBDPZXCVEOY-UHFFFAOYSA-N 0.000 description 1
- FDXLENUYTMXTEC-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(4-methoxyphenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CNC(=O)CC(CS1)N(C)C1=NC1CCCCCC1 FDXLENUYTMXTEC-UHFFFAOYSA-N 0.000 description 1
- OFIQOTSALRYEOV-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)-n-phenylacetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=CC=C1 OFIQOTSALRYEOV-UHFFFAOYSA-N 0.000 description 1
- GIXGTTTYLUFHGH-UHFFFAOYSA-N 2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetic acid;hydrochloride Chemical compound Cl.CN1C(CC(O)=O)CSC1=NC1CCCCCC1 GIXGTTTYLUFHGH-UHFFFAOYSA-N 0.000 description 1
- QPYZZXKDPQNOLW-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-5-nitrophenyl)acetamide Chemical compound CN1C(CC(=O)NC=2C(=CC=C(C=2)[N+]([O-])=O)F)C(C)SC1=NC1CCCCC1 QPYZZXKDPQNOLW-UHFFFAOYSA-N 0.000 description 1
- GDUKWAPTWIOCKD-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide Chemical compound CN1C(CC(=O)NC=2C=C(Cl)C=C(Cl)C=2)C(C)SC1=NC1CCCCC1 GDUKWAPTWIOCKD-UHFFFAOYSA-N 0.000 description 1
- MAHSBWWFOUMFEK-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(3-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=C(F)C=CC=2)C(C)SC1=NC1CCCCC1 MAHSBWWFOUMFEK-UHFFFAOYSA-N 0.000 description 1
- DHJVQGHRLAEJHU-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(C(C)S1)N(C)C1=NC1CCCCC1 DHJVQGHRLAEJHU-UHFFFAOYSA-N 0.000 description 1
- UCKPFWNGFXHGII-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(F)=CC=2)C(C)SC1=NC1CCCCC1 UCKPFWNGFXHGII-UHFFFAOYSA-N 0.000 description 1
- HVJLXKODXZKVEH-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1NC(=O)CC(C(C)S1)N(C)C1=NC1CCCCC1 HVJLXKODXZKVEH-UHFFFAOYSA-N 0.000 description 1
- OQOXBWWPLCTSBD-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(=CC=2)[N+]([O-])=O)C(C)SC1=NC1CCCCC1 OQOXBWWPLCTSBD-UHFFFAOYSA-N 0.000 description 1
- KBXIFLJXZWBTHR-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(C(C)S1)N(C)C1=NC1CCCCC1 KBXIFLJXZWBTHR-UHFFFAOYSA-N 0.000 description 1
- SUQSNSVZEBGBLP-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-[4-(trifluoromethoxy)phenyl]acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(OC(F)(F)F)=CC=2)C(C)SC1=NC1CCCCC1 SUQSNSVZEBGBLP-UHFFFAOYSA-N 0.000 description 1
- KLMZYVWEQFFXMP-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(=CC=2)C(F)(F)F)C(C)SC1=NC1CCCCC1 KLMZYVWEQFFXMP-UHFFFAOYSA-N 0.000 description 1
- TZPDUKHHGQTAFK-UHFFFAOYSA-N 2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-phenylacetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC=CC=2)C(C)SC1=NC1CCCCC1 TZPDUKHHGQTAFK-UHFFFAOYSA-N 0.000 description 1
- JQJRVAWQUJSXDK-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidin-4-yl)-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1CCCCC1 JQJRVAWQUJSXDK-UHFFFAOYSA-N 0.000 description 1
- PLCCWLVBUJLYFA-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidin-4-yl)-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1CCCCC1 PLCCWLVBUJLYFA-UHFFFAOYSA-N 0.000 description 1
- CBWSVCIXSHCKHM-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C=1C=C(OC=2C=CC=CC=2)C=CC=1NC(=O)CC(N1C2CC2)CSC1=NC1CCCCC1 CBWSVCIXSHCKHM-UHFFFAOYSA-N 0.000 description 1
- JPMCUFHNOPRNMN-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidin-4-yl)-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(C(F)(F)F)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1CCCCC1 JPMCUFHNOPRNMN-UHFFFAOYSA-N 0.000 description 1
- GJIIVHXAYYHVLV-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F GJIIVHXAYYHVLV-UHFFFAOYSA-N 0.000 description 1
- IKKNDSSGVKPLBD-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 IKKNDSSGVKPLBD-UHFFFAOYSA-N 0.000 description 1
- YOIHKRPTWSHOHL-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NC1=CC=C(F)C=C1 YOIHKRPTWSHOHL-UHFFFAOYSA-N 0.000 description 1
- URNYPCPYNFPPPC-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NC1=CC=C(C)C=C1 URNYPCPYNFPPPC-UHFFFAOYSA-N 0.000 description 1
- GRVMMGOKBZHWML-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 GRVMMGOKBZHWML-UHFFFAOYSA-N 0.000 description 1
- SXOQPPIOVAZZJG-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)-n-[(4-methylphenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NCC1=CC=C(C)C=C1 SXOQPPIOVAZZJG-UHFFFAOYSA-N 0.000 description 1
- FZOLDMAWWNVYPB-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 FZOLDMAWWNVYPB-UHFFFAOYSA-N 0.000 description 1
- BJYPNSMCOIZMSV-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2,3-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=CC(Cl)=C1Cl BJYPNSMCOIZMSV-UHFFFAOYSA-N 0.000 description 1
- SVSWVEMVYNVUCY-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2,4,5-trichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC(Cl)=C(Cl)C=C1Cl SVSWVEMVYNVUCY-UHFFFAOYSA-N 0.000 description 1
- CNZPEBNNJOLCPJ-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2,4-difluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1F CNZPEBNNJOLCPJ-UHFFFAOYSA-N 0.000 description 1
- QXHADPVKJCGRER-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2,5-dichloro-4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC(Cl)=C(C)C=C1Cl QXHADPVKJCGRER-UHFFFAOYSA-N 0.000 description 1
- QCTLZBLHPJSZEW-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC(Cl)=CC=C1Cl QCTLZBLHPJSZEW-UHFFFAOYSA-N 0.000 description 1
- XJMVJVISBZDYGF-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F XJMVJVISBZDYGF-UHFFFAOYSA-N 0.000 description 1
- XYPYUKMWHUMBGU-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3,4-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(Cl)C(Cl)=C1 XYPYUKMWHUMBGU-UHFFFAOYSA-N 0.000 description 1
- RTDKRJTWZYSDAO-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3,4-dimethoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCCC1 RTDKRJTWZYSDAO-UHFFFAOYSA-N 0.000 description 1
- DYGNDDGCWZWCMC-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 DYGNDDGCWZWCMC-UHFFFAOYSA-N 0.000 description 1
- FSXYGIPTNZURFJ-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3,5-difluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC(F)=CC(F)=C1 FSXYGIPTNZURFJ-UHFFFAOYSA-N 0.000 description 1
- RWICOPRDMBCLCO-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3-fluoro-4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(C)C(F)=C1 RWICOPRDMBCLCO-UHFFFAOYSA-N 0.000 description 1
- OVFPEUPULYNYJK-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=CC(F)=C1 OVFPEUPULYNYJK-UHFFFAOYSA-N 0.000 description 1
- VEODPQLOEZZKBB-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3-methoxyphenyl)acetamide;hydrochloride Chemical compound Cl.COC1=CC=CC(NC(=O)CC2N(C(=NC3CCCCC3)SC2)C)=C1 VEODPQLOEZZKBB-UHFFFAOYSA-N 0.000 description 1
- FITCICPBEIEXRT-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=CC([N+]([O-])=O)=C1 FITCICPBEIEXRT-UHFFFAOYSA-N 0.000 description 1
- BJXDVJFLKNJFSO-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.CC(C)C1=CC=CC(NC(=O)CC2N(C(=NC3CCCCC3)SC2)C)=C1 BJXDVJFLKNJFSO-UHFFFAOYSA-N 0.000 description 1
- NRXVRBQNTBFWJT-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1 NRXVRBQNTBFWJT-UHFFFAOYSA-N 0.000 description 1
- SADGGVWWJRQGKH-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(C)C=C1 SADGGVWWJRQGKH-UHFFFAOYSA-N 0.000 description 1
- IRGYUBDMOWAGMN-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 IRGYUBDMOWAGMN-UHFFFAOYSA-N 0.000 description 1
- UKMMRBCQIRSCEO-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(2-methylphenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NCC1=CC=CC=C1C UKMMRBCQIRSCEO-UHFFFAOYSA-N 0.000 description 1
- VSPVPEMYVNFZDW-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(3,4-dichlorophenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NCC1=CC=C(Cl)C(Cl)=C1 VSPVPEMYVNFZDW-UHFFFAOYSA-N 0.000 description 1
- CLQVFVOLNSFFKX-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(4-fluorophenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NCC1=CC=C(F)C=C1 CLQVFVOLNSFFKX-UHFFFAOYSA-N 0.000 description 1
- DAPRSXWQMLGWHH-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(4-methoxyphenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CNC(=O)CC(CS1)N(C)C1=NC1CCCCC1 DAPRSXWQMLGWHH-UHFFFAOYSA-N 0.000 description 1
- CGSJBHNFLLYCAY-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[2-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=CC=C1C(F)(F)F CGSJBHNFLLYCAY-UHFFFAOYSA-N 0.000 description 1
- NCUFEUONDZCPSK-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[3-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=CC(C(F)(F)F)=C1 NCUFEUONDZCPSK-UHFFFAOYSA-N 0.000 description 1
- GKUIKQNIJZLYCD-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 GKUIKQNIJZLYCD-UHFFFAOYSA-N 0.000 description 1
- SYQIMMFSXJNFFB-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F SYQIMMFSXJNFFB-UHFFFAOYSA-N 0.000 description 1
- CRJMCINLUXLJQE-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 CRJMCINLUXLJQE-UHFFFAOYSA-N 0.000 description 1
- BFJYDMFFXOTNAA-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC=C(CC)C=C1 BFJYDMFFXOTNAA-UHFFFAOYSA-N 0.000 description 1
- MZMXCBTUVDJLGU-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC=C(F)C=C1 MZMXCBTUVDJLGU-UHFFFAOYSA-N 0.000 description 1
- BQBOVMCSUVGALN-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC=C(C)C=C1 BQBOVMCSUVGALN-UHFFFAOYSA-N 0.000 description 1
- FLGANCKYQDCFFN-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 FLGANCKYQDCFFN-UHFFFAOYSA-N 0.000 description 1
- MRTWOCNINYPTRG-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC=C(C(C)C)C=C1 MRTWOCNINYPTRG-UHFFFAOYSA-N 0.000 description 1
- ZVZVYYRYWURAID-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)-n-[(4-methylphenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NCC1=CC=C(C)C=C1 ZVZVYYRYWURAID-UHFFFAOYSA-N 0.000 description 1
- SDJKKUPZRGHHHQ-UHFFFAOYSA-N 2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 SDJKKUPZRGHHHQ-UHFFFAOYSA-N 0.000 description 1
- UYLLTXDBDYDFAO-UHFFFAOYSA-N 2-(2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C(=CC=CC=2)F)C(C)SC1=NC1CCCC1 UYLLTXDBDYDFAO-UHFFFAOYSA-N 0.000 description 1
- WLBJYTKHSZMOAJ-UHFFFAOYSA-N 2-(2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(C)=CC=2)C(C)SC1=NC1CCCC1 WLBJYTKHSZMOAJ-UHFFFAOYSA-N 0.000 description 1
- XGYZDIQLMCYAIW-UHFFFAOYSA-N 2-(2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)-n-phenylacetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC=CC=2)C(C)SC1=NC1CCCC1 XGYZDIQLMCYAIW-UHFFFAOYSA-N 0.000 description 1
- NFPKRQFKIAASLC-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2,4-difluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1F NFPKRQFKIAASLC-UHFFFAOYSA-N 0.000 description 1
- SVUZIVFEJQIQMY-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC=C(C)C=C1F SVUZIVFEJQIQMY-UHFFFAOYSA-N 0.000 description 1
- GBSWOPPHFMHKQK-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F GBSWOPPHFMHKQK-UHFFFAOYSA-N 0.000 description 1
- RIZRGLNPMFCWOX-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 RIZRGLNPMFCWOX-UHFFFAOYSA-N 0.000 description 1
- AUXHOSYNUOKHIZ-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-methoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCC1 AUXHOSYNUOKHIZ-UHFFFAOYSA-N 0.000 description 1
- COVHDNDPRPGIDS-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 COVHDNDPRPGIDS-UHFFFAOYSA-N 0.000 description 1
- CDLQFVYKNHLTMN-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCC1 CDLQFVYKNHLTMN-UHFFFAOYSA-N 0.000 description 1
- DCNQLMNXWGVWHC-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(4-fluorophenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NCC1=CC=C(F)C=C1 DCNQLMNXWGVWHC-UHFFFAOYSA-N 0.000 description 1
- RJLQHABIZVKGQR-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(4-methoxyphenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CNC(=O)CC(CS1)N(C)C1=NC1CCCC1 RJLQHABIZVKGQR-UHFFFAOYSA-N 0.000 description 1
- XBJWVILESXXOET-UHFFFAOYSA-N 2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)-n-phenylacetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC=CC=C1 XBJWVILESXXOET-UHFFFAOYSA-N 0.000 description 1
- UJJIRZZXWOVFME-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2,4-difluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1F UJJIRZZXWOVFME-UHFFFAOYSA-N 0.000 description 1
- RCSCWLDQWIDRJY-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=C(C)C=C1F RCSCWLDQWIDRJY-UHFFFAOYSA-N 0.000 description 1
- DYTYEXUWQOAWEC-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F DYTYEXUWQOAWEC-UHFFFAOYSA-N 0.000 description 1
- RFYUNRVQHVEXBV-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 RFYUNRVQHVEXBV-UHFFFAOYSA-N 0.000 description 1
- ARNZYFBZPNTELB-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-ethoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(OCC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CC1 ARNZYFBZPNTELB-UHFFFAOYSA-N 0.000 description 1
- ZMRXLSBEFWVMFX-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1 ZMRXLSBEFWVMFX-UHFFFAOYSA-N 0.000 description 1
- JJWPNVWZOVJNNV-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-methoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CC1 JJWPNVWZOVJNNV-UHFFFAOYSA-N 0.000 description 1
- BVUXIPIYAYYFHL-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 BVUXIPIYAYYFHL-UHFFFAOYSA-N 0.000 description 1
- PNQDHRDLUUARMC-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CC1 PNQDHRDLUUARMC-UHFFFAOYSA-N 0.000 description 1
- HIEBJPYVNPSSRI-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(4-fluorophenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NCC1=CC=C(F)C=C1 HIEBJPYVNPSSRI-UHFFFAOYSA-N 0.000 description 1
- LEAPFNXIIHMYIL-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-[(4-methoxyphenyl)methyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CNC(=O)CC(CS1)N(C)C1=NC1CC1 LEAPFNXIIHMYIL-UHFFFAOYSA-N 0.000 description 1
- VGFMKOHPBUUMEE-UHFFFAOYSA-N 2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)-n-phenylacetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=CC=C1 VGFMKOHPBUUMEE-UHFFFAOYSA-N 0.000 description 1
- IOYHBMZHYFJDQK-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.[O-][N+](=O)C1=CC=C(F)C(NC(=O)CC2N(C(=NC3CCCCC3)SC2)CC=2C=CC=CC=2)=C1 IOYHBMZHYFJDQK-UHFFFAOYSA-N 0.000 description 1
- UZUCDTPDWZKTLM-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.ClC1=CC(Cl)=CC(NC(=O)CC2N(C(=NC3CCCCC3)SC2)CC=2C=CC=CC=2)=C1 UZUCDTPDWZKTLM-UHFFFAOYSA-N 0.000 description 1
- YLLKNFNVVJOVJK-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-bromophenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(Br)=CC=C1NC(=O)CC(CS1)N(CC=2C=CC=CC=2)C1=NC1CCCCC1 YLLKNFNVVJOVJK-UHFFFAOYSA-N 0.000 description 1
- MLFKCXDKZXUZJK-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-butylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(CC=2C=CC=CC=2)C1=NC1CCCCC1 MLFKCXDKZXUZJK-UHFFFAOYSA-N 0.000 description 1
- UPMURFIXLMABIQ-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-chlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1NC(=O)CC(CS1)N(CC=2C=CC=CC=2)C1=NC1CCCCC1 UPMURFIXLMABIQ-UHFFFAOYSA-N 0.000 description 1
- YXOQKMXJLFDSLS-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(CS1)N(CC=2C=CC=CC=2)C1=NC1CCCCC1 YXOQKMXJLFDSLS-UHFFFAOYSA-N 0.000 description 1
- ASVVKYSOFHQRIN-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(F)=CC=C1NC(=O)CC(CS1)N(CC=2C=CC=CC=2)C1=NC1CCCCC1 ASVVKYSOFHQRIN-UHFFFAOYSA-N 0.000 description 1
- NJMDCERWSGMZPR-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C=1C=C(OC=2C=CC=CC=2)C=CC=1NC(=O)CC(N1CC=2C=CC=CC=2)CSC1=NC1CCCCC1 NJMDCERWSGMZPR-UHFFFAOYSA-N 0.000 description 1
- MFZRTLDLJWJMNR-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(CC=2C=CC=CC=2)C1=NC1CCCCC1 MFZRTLDLJWJMNR-UHFFFAOYSA-N 0.000 description 1
- XCVSFIDVIIGCHE-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(5-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.FC1=CC=C(Cl)C=C1NC(=O)CC(CS1)N(CC=2C=CC=CC=2)C1=NC1CCCCC1 XCVSFIDVIIGCHE-UHFFFAOYSA-N 0.000 description 1
- JUHKDPDLZXKOPX-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-[3,5-bis(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC(C(F)(F)F)=CC(NC(=O)CC2N(C(=NC3CCCCC3)SC2)CC=2C=CC=CC=2)=C1 JUHKDPDLZXKOPX-UHFFFAOYSA-N 0.000 description 1
- UMNUDYOCTQXBMR-UHFFFAOYSA-N 2-(3-benzyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(C(F)(F)F)=CC=C1NC(=O)CC(CS1)N(CC=2C=CC=CC=2)C1=NC1CCCCC1 UMNUDYOCTQXBMR-UHFFFAOYSA-N 0.000 description 1
- WHBRESCTLWLMLW-UHFFFAOYSA-N 2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(2-chloro-4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC1=CC=C(C)C=C1Cl WHBRESCTLWLMLW-UHFFFAOYSA-N 0.000 description 1
- ZLKFBUPJSACIEW-UHFFFAOYSA-N 2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 ZLKFBUPJSACIEW-UHFFFAOYSA-N 0.000 description 1
- MLSUDCKVBLKTCP-UHFFFAOYSA-N 2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-butylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC1=CC=C(CCCC)C=C1 MLSUDCKVBLKTCP-UHFFFAOYSA-N 0.000 description 1
- KBDBPMADSIJPPU-UHFFFAOYSA-N 2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-chlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC1=CC=C(Cl)C=C1 KBDBPMADSIJPPU-UHFFFAOYSA-N 0.000 description 1
- KYRLODNVNBJBIM-UHFFFAOYSA-N 2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC1=CC=C(CC)C=C1 KYRLODNVNBJBIM-UHFFFAOYSA-N 0.000 description 1
- ZHNSIKWEJCYNKZ-UHFFFAOYSA-N 2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC1=CC=C(F)C=C1 ZHNSIKWEJCYNKZ-UHFFFAOYSA-N 0.000 description 1
- QMPOETISWXSAIH-UHFFFAOYSA-N 2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC1=CC=C(C)C=C1 QMPOETISWXSAIH-UHFFFAOYSA-N 0.000 description 1
- LUNVKOGXCOSLKL-UHFFFAOYSA-N 2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 LUNVKOGXCOSLKL-UHFFFAOYSA-N 0.000 description 1
- KUYVKEWYOJRRKW-UHFFFAOYSA-N 2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC1=CC=C(C(C)C)C=C1 KUYVKEWYOJRRKW-UHFFFAOYSA-N 0.000 description 1
- UCJKAIBXKOETDH-UHFFFAOYSA-N 2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.ClC1=CC(Cl)=CC(NC(=O)CC2N(C(=NC3CCCCC3)SC2)C2CCCCC2)=C1 UCJKAIBXKOETDH-UHFFFAOYSA-N 0.000 description 1
- RJMPBCFHJOFRNX-UHFFFAOYSA-N 2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(F)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 RJMPBCFHJOFRNX-UHFFFAOYSA-N 0.000 description 1
- DZOVPJCEBWZGCF-UHFFFAOYSA-N 2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 DZOVPJCEBWZGCF-UHFFFAOYSA-N 0.000 description 1
- DQCURHQRLLTMPF-UHFFFAOYSA-N 2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)-n-[[2-(trifluoromethyl)phenyl]methyl]acetamide;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC=CC=C1CNC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 DQCURHQRLLTMPF-UHFFFAOYSA-N 0.000 description 1
- QQOMUWRFBPGNKB-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 QQOMUWRFBPGNKB-UHFFFAOYSA-N 0.000 description 1
- DCBLZTFPJDMRQL-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(4-bromophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC=C(Br)C=C1 DCBLZTFPJDMRQL-UHFFFAOYSA-N 0.000 description 1
- ZQYVPMSRQWVZFG-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(4-butylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC=C(CCCC)C=C1 ZQYVPMSRQWVZFG-UHFFFAOYSA-N 0.000 description 1
- KOPLXZVEOTVJFW-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(4-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC=C(Cl)C=C1F KOPLXZVEOTVJFW-UHFFFAOYSA-N 0.000 description 1
- FYBULJYYRKBUQZ-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(4-chlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC=C(Cl)C=C1 FYBULJYYRKBUQZ-UHFFFAOYSA-N 0.000 description 1
- YRFIOYKJOATZBP-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC=C(CC)C=C1 YRFIOYKJOATZBP-UHFFFAOYSA-N 0.000 description 1
- ZVLULLFSBRLTCK-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC=C(F)C=C1 ZVLULLFSBRLTCK-UHFFFAOYSA-N 0.000 description 1
- YCCBILGQPGOSKK-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC=C(C)C=C1 YCCBILGQPGOSKK-UHFFFAOYSA-N 0.000 description 1
- GIYDAJJMBBGQLQ-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 GIYDAJJMBBGQLQ-UHFFFAOYSA-N 0.000 description 1
- WXDLBJIXACNQLA-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC=C(C(C)C)C=C1 WXDLBJIXACNQLA-UHFFFAOYSA-N 0.000 description 1
- CDBQCFQSPKQJHM-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-(5-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC(Cl)=CC=C1F CDBQCFQSPKQJHM-UHFFFAOYSA-N 0.000 description 1
- UQXZMKMDBDLZTA-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-[3,5-bis(fluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC(CF)=CC(CF)=C1 UQXZMKMDBDLZTA-UHFFFAOYSA-N 0.000 description 1
- VERRIUZWDPJUPS-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-butyl-1,3-thiazolidin-4-yl]-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCCC)C1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 VERRIUZWDPJUPS-UHFFFAOYSA-N 0.000 description 1
- ZVWXMXOCXKAZCF-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidin-4-yl]-n-(4-butylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1(C2)CC(C3)CC2CC3C1 ZVWXMXOCXKAZCF-UHFFFAOYSA-N 0.000 description 1
- OCKDHZFLNYBENX-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidin-4-yl]-n-(4-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.FC1=CC(Cl)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1(C2)CC(C3)CC2CC3C1 OCKDHZFLNYBENX-UHFFFAOYSA-N 0.000 description 1
- LVGWBRALRNTZJS-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidin-4-yl]-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1(C2)CC(C3)CC2CC3C1 LVGWBRALRNTZJS-UHFFFAOYSA-N 0.000 description 1
- BYRJLTICKMSFER-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidin-4-yl]-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C=1C=C(OC=2C=CC=CC=2)C=CC=1NC(=O)CC1CSC(=NC23CC4CC(CC(C4)C2)C3)N1C1CC1 BYRJLTICKMSFER-UHFFFAOYSA-N 0.000 description 1
- OLBQIEMSJWNWQT-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1(C2)CC(C3)CC2CC3C1 OLBQIEMSJWNWQT-UHFFFAOYSA-N 0.000 description 1
- WAQRMOCUXCFQGJ-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidin-4-yl]-n-(5-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.FC1=CC=C(Cl)C=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1(C2)CC(C3)CC2CC3C1 WAQRMOCUXCFQGJ-UHFFFAOYSA-N 0.000 description 1
- GOAGNJKBTZLUGJ-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidin-4-yl]-n-[3,5-bis(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC(C(F)(F)F)=CC(NC(=O)CC2N(C(=NC34CC5CC(CC(C5)C3)C4)SC2)C2CC2)=C1 GOAGNJKBTZLUGJ-UHFFFAOYSA-N 0.000 description 1
- ILLFGBDRTFBYDC-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidin-4-yl]-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(C(F)(F)F)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1(C2)CC(C3)CC2CC3C1 ILLFGBDRTFBYDC-UHFFFAOYSA-N 0.000 description 1
- ANFVATQAGGKNKU-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-ethyl-1,3-thiazolidin-4-yl]-n-(4-butylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(CC)C1=NC1(C2)CC(C3)CC2CC3C1 ANFVATQAGGKNKU-UHFFFAOYSA-N 0.000 description 1
- FUUOJVVQUUDVOX-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-ethyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CC)C1CC(=O)NC1=CC=C(C(C)C)C=C1 FUUOJVVQUUDVOX-UHFFFAOYSA-N 0.000 description 1
- QSLHTPPHUWCGLL-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-ethyl-1,3-thiazolidin-4-yl]-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CC)C1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 QSLHTPPHUWCGLL-UHFFFAOYSA-N 0.000 description 1
- VCPPNXDMWOALOV-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(2-chloro-4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC1=CC=C(C)C=C1Cl VCPPNXDMWOALOV-UHFFFAOYSA-N 0.000 description 1
- SSPDHPSWGHCIOV-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 SSPDHPSWGHCIOV-UHFFFAOYSA-N 0.000 description 1
- MRYMASHKZIIFBO-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-bromophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC1=CC=C(Br)C=C1 MRYMASHKZIIFBO-UHFFFAOYSA-N 0.000 description 1
- HYDSRNBRCPWKJI-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-chlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 HYDSRNBRCPWKJI-UHFFFAOYSA-N 0.000 description 1
- FPACRKLACGWGGR-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1(C2)CC(C3)CC2CC3C1 FPACRKLACGWGGR-UHFFFAOYSA-N 0.000 description 1
- VUEHCSUXBMTYRV-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-methoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1(C2)CC(C3)CC2CC3C1 VUEHCSUXBMTYRV-UHFFFAOYSA-N 0.000 description 1
- FWFFGRJXCKWGLE-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC1=CC=C(C)C=C1 FWFFGRJXCKWGLE-UHFFFAOYSA-N 0.000 description 1
- AUGOHPLZROGXMC-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 AUGOHPLZROGXMC-UHFFFAOYSA-N 0.000 description 1
- VKCQYFSVFMCTAX-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1(C2)CC(C3)CC2CC3C1 VKCQYFSVFMCTAX-UHFFFAOYSA-N 0.000 description 1
- QURJEYVSXHCPFR-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(5-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC1=CC(Cl)=CC=C1F QURJEYVSXHCPFR-UHFFFAOYSA-N 0.000 description 1
- QEEDSTGNHJQTHU-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-[3,5-bis(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 QEEDSTGNHJQTHU-UHFFFAOYSA-N 0.000 description 1
- KZAUVIPDYDEGHN-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C)C1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 KZAUVIPDYDEGHN-UHFFFAOYSA-N 0.000 description 1
- OKEIXKCTDHNWOP-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F OKEIXKCTDHNWOP-UHFFFAOYSA-N 0.000 description 1
- YKYJVTXPWLWHKD-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-(3-chloro-4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC1=CC=C(C)C(Cl)=C1 YKYJVTXPWLWHKD-UHFFFAOYSA-N 0.000 description 1
- HXGXJKVJLAYJAM-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-(4-butylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(C(C)C)C1=NC1(C2)CC(C3)CC2CC3C1 HXGXJKVJLAYJAM-UHFFFAOYSA-N 0.000 description 1
- HSLXUDHKDYEESM-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-(4-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC1=CC=C(Cl)C=C1F HSLXUDHKDYEESM-UHFFFAOYSA-N 0.000 description 1
- HVBHXAJVXADJIU-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-(4-chlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC1=CC=C(Cl)C=C1 HVBHXAJVXADJIU-UHFFFAOYSA-N 0.000 description 1
- RRFDEWNBTAENIN-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1NC(=O)CC(CS1)N(C(C)C)C1=NC1(C2)CC(C3)CC2CC3C1 RRFDEWNBTAENIN-UHFFFAOYSA-N 0.000 description 1
- MBBWISBJQPCPDK-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC1=CC=C(C)C=C1 MBBWISBJQPCPDK-UHFFFAOYSA-N 0.000 description 1
- KNSJNTGPYFKJLL-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 KNSJNTGPYFKJLL-UHFFFAOYSA-N 0.000 description 1
- WBCKSHNXJKTNEP-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-(5-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC1=CC(Cl)=CC=C1F WBCKSHNXJKTNEP-UHFFFAOYSA-N 0.000 description 1
- OPHYTHJFZPRBND-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-[3,5-bis(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 OPHYTHJFZPRBND-UHFFFAOYSA-N 0.000 description 1
- GHWDGDUMXVXZIN-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-[4-(fluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC1=CC=C(CF)C=C1 GHWDGDUMXVXZIN-UHFFFAOYSA-N 0.000 description 1
- WPXUCLRRYKJZJT-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propan-2-yl-1,3-thiazolidin-4-yl]-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(C(C)C)C1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 WPXUCLRRYKJZJT-UHFFFAOYSA-N 0.000 description 1
- IPWUDKSSDWXRAL-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(2-chloro-4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC=C(C)C=C1Cl IPWUDKSSDWXRAL-UHFFFAOYSA-N 0.000 description 1
- KRBTXBDLIPMDRX-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F KRBTXBDLIPMDRX-UHFFFAOYSA-N 0.000 description 1
- DTPXTTVDBAZSCL-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(3,5-dichlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 DTPXTTVDBAZSCL-UHFFFAOYSA-N 0.000 description 1
- QYMUBLQTFVSDSJ-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(4-bromophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC=C(Br)C=C1 QYMUBLQTFVSDSJ-UHFFFAOYSA-N 0.000 description 1
- UJPZIEFALABJHE-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(4-butylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(CCC)C1=NC1(C2)CC(C3)CC2CC3C1 UJPZIEFALABJHE-UHFFFAOYSA-N 0.000 description 1
- APKPGOJCJUMOOV-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(4-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC=C(Cl)C=C1F APKPGOJCJUMOOV-UHFFFAOYSA-N 0.000 description 1
- ZKBPMXBIORBELE-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(4-ethylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC=C(CC)C=C1 ZKBPMXBIORBELE-UHFFFAOYSA-N 0.000 description 1
- QITMGXZGTOWUSI-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC=C(F)C=C1 QITMGXZGTOWUSI-UHFFFAOYSA-N 0.000 description 1
- LKFQCPQFDONWER-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(4-methylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC=C(C)C=C1 LKFQCPQFDONWER-UHFFFAOYSA-N 0.000 description 1
- RFUVGNPTXPXGDF-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 RFUVGNPTXPXGDF-UHFFFAOYSA-N 0.000 description 1
- YHHAZZRXZYEVBC-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC=C(C(C)C)C=C1 YHHAZZRXZYEVBC-UHFFFAOYSA-N 0.000 description 1
- FCJYOMVRHGGMSC-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(5-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC(Cl)=CC=C1F FCJYOMVRHGGMSC-UHFFFAOYSA-N 0.000 description 1
- OLVVVTXSSKKRTK-UHFFFAOYSA-N 2-[2-(1-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-[4-(trifluoromethyl)phenyl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC23CC4CC(CC(C4)C2)C3)N(CCC)C1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 OLVVVTXSSKKRTK-UHFFFAOYSA-N 0.000 description 1
- FIFZKKOMIXLJFJ-UHFFFAOYSA-N 2-[2-(2-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-butylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1C(C2)CC3CC2CC1C3 FIFZKKOMIXLJFJ-UHFFFAOYSA-N 0.000 description 1
- KEXBSFZJBUIZEN-UHFFFAOYSA-N 2-[2-(2-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2C3CC4CC(C3)CC2C4)N(C)C1CC(=O)NC1=CC=C(F)C=C1 KEXBSFZJBUIZEN-UHFFFAOYSA-N 0.000 description 1
- KVRMCGGNNYYBSI-UHFFFAOYSA-N 2-[2-(2-adamantylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1C(C2)CC3CC2CC1C3 KVRMCGGNNYYBSI-UHFFFAOYSA-N 0.000 description 1
- ZXQMHXSUMLERMP-UHFFFAOYSA-N 2-[2-(2-adamantylimino)-3-propyl-1,3-thiazolidin-4-yl]-n-(4-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2C3CC4CC(C3)CC2C4)N(CCC)C1CC(=O)NC1=CC=C(Cl)C=C1F ZXQMHXSUMLERMP-UHFFFAOYSA-N 0.000 description 1
- BGBSEOBCZFXVLU-UHFFFAOYSA-N 2-[2-(3-bromophenyl)imino-3-methyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1=CC=CC(Br)=C1 BGBSEOBCZFXVLU-UHFFFAOYSA-N 0.000 description 1
- SEEXGSBPSMIGLW-UHFFFAOYSA-N 2-[2-(3-chloro-4-fluorophenyl)imino-3-methyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1=CC=C(F)C(Cl)=C1 SEEXGSBPSMIGLW-UHFFFAOYSA-N 0.000 description 1
- PKNONZDRWBSMAS-UHFFFAOYSA-N 2-[2-(4-bromophenyl)imino-3-methyl-1,3-thiazolidin-4-yl]-n-(4-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=CC(Br)=CC=2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F PKNONZDRWBSMAS-UHFFFAOYSA-N 0.000 description 1
- ROQCMMSDFVGRNZ-UHFFFAOYSA-N 2-[2-(4-butylphenyl)imino-3-methyl-1,3-thiazolidin-4-yl]-n-(4-chloro-2-fluorophenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1N=C1N(C)C(CC(=O)NC=2C(=CC(Cl)=CC=2)F)CS1 ROQCMMSDFVGRNZ-UHFFFAOYSA-N 0.000 description 1
- KZTMXWIYYCAPSO-UHFFFAOYSA-N 2-[2-(4-butylphenyl)imino-3-methyl-1,3-thiazolidin-4-yl]-n-(4-chlorophenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1N=C1N(C)C(CC(=O)NC=2C=CC(Cl)=CC=2)CS1 KZTMXWIYYCAPSO-UHFFFAOYSA-N 0.000 description 1
- RCRLBOANECOWHH-UHFFFAOYSA-N 2-[2-(4-chloro-2-fluoro-5-propan-2-yloxyphenyl)imino-3-methyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=C(Cl)C(OC(C)C)=CC(N=C2N(C(CC(=O)NC=3C=CC(=CC=3)C(C)C)CS2)C)=C1F RCRLBOANECOWHH-UHFFFAOYSA-N 0.000 description 1
- RGAUGXHJMYOECA-UHFFFAOYSA-N 2-[2-(4-cyanophenyl)imino-3-methyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1=CC=C(C#N)C=C1 RGAUGXHJMYOECA-UHFFFAOYSA-N 0.000 description 1
- LVSOTUHOQMLBRP-UHFFFAOYSA-N 2-[2-(cyclohexylmethylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(2-fluoro-5-nitrophenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NCC2CCCCC2)N(C)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F LVSOTUHOQMLBRP-UHFFFAOYSA-N 0.000 description 1
- IMKGXLSMRYOCBY-UHFFFAOYSA-N 2-[2-(cyclohexylmethylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NCC2CCCCC2)N(C)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 IMKGXLSMRYOCBY-UHFFFAOYSA-N 0.000 description 1
- NPHSEXUGPGOMSW-UHFFFAOYSA-N 2-[2-(cyclohexylmethylimino)-3-methyl-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NCC1CCCCC1 NPHSEXUGPGOMSW-UHFFFAOYSA-N 0.000 description 1
- XSIPGLRGYVEJQQ-UHFFFAOYSA-N 2-[3-methyl-2-(2-phenylethylimino)-1,3-thiazolidin-4-yl]-n-(4-phenoxyphenyl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NCCC=2C=CC=CC=2)N(C)C1CC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 XSIPGLRGYVEJQQ-UHFFFAOYSA-N 0.000 description 1
- GZAQIXFXAUSHGG-UHFFFAOYSA-N 2-[3-methyl-2-(2-phenylethylimino)-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NCCC1=CC=CC=C1 GZAQIXFXAUSHGG-UHFFFAOYSA-N 0.000 description 1
- YTQQEDRBHRLTEW-UHFFFAOYSA-N 2-[3-methyl-2-[4-(trifluoromethyl)phenyl]imino-1,3-thiazolidin-4-yl]-n-(4-propan-2-ylphenyl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1=CC=C(C(F)(F)F)C=C1 YTQQEDRBHRLTEW-UHFFFAOYSA-N 0.000 description 1
- DBFOKUZYYGSMCE-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-(4-methylphenyl)-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.CN1C(C(=O)NC=2C=CC(C)=CC=2)CSC1=NC1CCCCCC1 DBFOKUZYYGSMCE-UHFFFAOYSA-N 0.000 description 1
- YEDBWWPJGYGVDE-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-(4-methylphenyl)-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NC=2C=CC(C)=CC=2)CSC1=NC1CCCCCC1 YEDBWWPJGYGVDE-UHFFFAOYSA-N 0.000 description 1
- PSXKQHNDVZRAIK-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-(4-phenoxyphenyl)-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C=CC(OC=3C=CC=CC=3)=CC=2)CSC1=NC1CCCCCC1 PSXKQHNDVZRAIK-UHFFFAOYSA-N 0.000 description 1
- WDEWAFUBBZRWLK-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-(4-phenoxyphenyl)-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.CN1C(C(=O)NC=2C=CC(OC=3C=CC=CC=3)=CC=2)CSC1=NC1CCCCCC1 WDEWAFUBBZRWLK-UHFFFAOYSA-N 0.000 description 1
- QUPDBDHBMVRHSW-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-(4-propan-2-ylphenyl)-1,3-thiazolidine-4-carboxamide Chemical compound C1=CC(C(C)C)=CC=C1NC(=O)C(CS1)N(C)C1=NC1CCCCCC1 QUPDBDHBMVRHSW-UHFFFAOYSA-N 0.000 description 1
- DBOXYTWHLWLAHL-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-(4-propan-2-ylphenyl)-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.C1=CC(C(C)C)=CC=C1NC(=O)C(CS1)N(C)C1=NC1CCCCCC1 DBOXYTWHLWLAHL-UHFFFAOYSA-N 0.000 description 1
- HWCDFAOKLOUUTN-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-[[2-(trifluoromethyl)phenyl]methyl]-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NCC=2C(=CC=CC=2)C(F)(F)F)CSC1=NC1CCCCCC1 HWCDFAOKLOUUTN-UHFFFAOYSA-N 0.000 description 1
- UJKKSJSSZIWORC-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-[[2-(trifluoromethyl)phenyl]methyl]-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.CN1C(C(=O)NCC=2C(=CC=CC=2)C(F)(F)F)CSC1=NC1CCCCCC1 UJKKSJSSZIWORC-UHFFFAOYSA-N 0.000 description 1
- XIBSMPMAZAOGIO-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-phenyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C=CC=CC=2)CSC1=NC1CCCCCC1 XIBSMPMAZAOGIO-UHFFFAOYSA-N 0.000 description 1
- POGHNMIIRHECTG-UHFFFAOYSA-N 2-cycloheptylimino-3-methyl-N-phenyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NC=2C=CC=CC=2)CSC1=NC1CCCCCC1 POGHNMIIRHECTG-UHFFFAOYSA-N 0.000 description 1
- HCITTYCRVKDZMB-UHFFFAOYSA-N 2-cycloheptylimino-N-(2,5-difluorophenyl)-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C(=CC=C(F)C=2)F)CSC1=NC1CCCCCC1 HCITTYCRVKDZMB-UHFFFAOYSA-N 0.000 description 1
- ONSKUQFLWDGEBJ-UHFFFAOYSA-N 2-cycloheptylimino-N-(2,5-difluorophenyl)-3-methyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NC=2C(=CC=C(F)C=2)F)CSC1=NC1CCCCCC1 ONSKUQFLWDGEBJ-UHFFFAOYSA-N 0.000 description 1
- DQYSXUKYQNXMOZ-UHFFFAOYSA-N 2-cycloheptylimino-N-(2-fluoro-5-nitrophenyl)-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C(=CC=C(C=2)[N+]([O-])=O)F)CSC1=NC1CCCCCC1 DQYSXUKYQNXMOZ-UHFFFAOYSA-N 0.000 description 1
- MXZVXHXHQKNFHS-UHFFFAOYSA-N 2-cycloheptylimino-N-(2-fluoro-5-nitrophenyl)-3-methyl-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.CN1C(C(=O)NC=2C(=CC=C(C=2)[N+]([O-])=O)F)CSC1=NC1CCCCCC1 MXZVXHXHQKNFHS-UHFFFAOYSA-N 0.000 description 1
- COUIEVLXEFVJRG-UHFFFAOYSA-N 2-cycloheptylimino-N-(3,4-difluorophenyl)-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C=C(F)C(F)=CC=2)CSC1=NC1CCCCCC1 COUIEVLXEFVJRG-UHFFFAOYSA-N 0.000 description 1
- SVOMENDTOCBGBM-UHFFFAOYSA-N 2-cycloheptylimino-N-(3,5-dichlorophenyl)-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C=C(Cl)C=C(Cl)C=2)CSC1=NC1CCCCCC1 SVOMENDTOCBGBM-UHFFFAOYSA-N 0.000 description 1
- FKJTZTQWGNKOOJ-UHFFFAOYSA-N 2-cycloheptylimino-N-(4-ethylphenyl)-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C(CS1)N(C)C1=NC1CCCCCC1 FKJTZTQWGNKOOJ-UHFFFAOYSA-N 0.000 description 1
- IRABLMIYMWLTHX-UHFFFAOYSA-N 2-cycloheptylimino-N-(4-ethylphenyl)-3-methyl-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.C1=CC(CC)=CC=C1NC(=O)C(CS1)N(C)C1=NC1CCCCCC1 IRABLMIYMWLTHX-UHFFFAOYSA-N 0.000 description 1
- RBNBXIPOUXHRIK-UHFFFAOYSA-N 2-cycloheptylimino-N-(4-fluorophenyl)-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C=CC(F)=CC=2)CSC1=NC1CCCCCC1 RBNBXIPOUXHRIK-UHFFFAOYSA-N 0.000 description 1
- GLLCGSRFYYISEX-UHFFFAOYSA-N 2-cycloheptylimino-N-(4-fluorophenyl)-3-methyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NC=2C=CC(F)=CC=2)CSC1=NC1CCCCCC1 GLLCGSRFYYISEX-UHFFFAOYSA-N 0.000 description 1
- UKYLDZLNTXWYBN-UHFFFAOYSA-N 2-cycloheptylimino-N-[(3,4-dichlorophenyl)methyl]-3-methyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NCC=2C=C(Cl)C(Cl)=CC=2)CSC1=NC1CCCCCC1 UKYLDZLNTXWYBN-UHFFFAOYSA-N 0.000 description 1
- LBVCVAHTHYVDKJ-UHFFFAOYSA-N 2-cycloheptylimino-N-[(3-fluorophenyl)methyl]-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NCC=2C=C(F)C=CC=2)CSC1=NC1CCCCCC1 LBVCVAHTHYVDKJ-UHFFFAOYSA-N 0.000 description 1
- WZQQIEKSZKIUPQ-UHFFFAOYSA-N 2-cycloheptylimino-N-[(3-fluorophenyl)methyl]-3-methyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NCC=2C=C(F)C=CC=2)CSC1=NC1CCCCCC1 WZQQIEKSZKIUPQ-UHFFFAOYSA-N 0.000 description 1
- UDYKHOFPZVGZCA-UHFFFAOYSA-N 2-cycloheptylimino-N-[(4-methoxyphenyl)methyl]-3-methyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CNC(=O)C(CS1)N(C)C1=NC1CCCCCC1 UDYKHOFPZVGZCA-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- CSFDTBRRIBJILD-UHFFFAOYSA-N 4-chloro-2-fluoroaniline Chemical compound NC1=CC=C(Cl)C=C1F CSFDTBRRIBJILD-UHFFFAOYSA-N 0.000 description 1
- RZIFCSAHKZANJB-UHFFFAOYSA-N 4-chloro-3-oxo-n-(4-phenoxyphenyl)butanamide Chemical compound C1=CC(NC(=O)CC(=O)CCl)=CC=C1OC1=CC=CC=C1 RZIFCSAHKZANJB-UHFFFAOYSA-N 0.000 description 1
- WOYZXEVUWXQVNV-UHFFFAOYSA-N 4-phenoxyaniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC=C1 WOYZXEVUWXQVNV-UHFFFAOYSA-N 0.000 description 1
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 101150104494 CAV1 gene Proteins 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 101150047856 Cav2 gene Proteins 0.000 description 1
- 101150110214 Cav3 gene Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000944277 Homo sapiens Inward rectifier potassium channel 2 Proteins 0.000 description 1
- 101000867850 Homo sapiens Voltage-dependent T-type calcium channel subunit alpha-1G Proteins 0.000 description 1
- 101000932804 Homo sapiens Voltage-dependent T-type calcium channel subunit alpha-1H Proteins 0.000 description 1
- 101000932785 Homo sapiens Voltage-dependent T-type calcium channel subunit alpha-1I Proteins 0.000 description 1
- 102100033114 Inward rectifier potassium channel 2 Human genes 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- GUOXSIKVRRRYTL-UHFFFAOYSA-N N-(2-bromophenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NC=2C(=CC=CC=2)Br)CSC1=NC1CCCCCC1 GUOXSIKVRRRYTL-UHFFFAOYSA-N 0.000 description 1
- DGLSUBIJHGSTGN-UHFFFAOYSA-N N-(2-chlorophenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C(=CC=CC=2)Cl)CSC1=NC1CCCCCC1 DGLSUBIJHGSTGN-UHFFFAOYSA-N 0.000 description 1
- AKGQDKLGLYWYLP-UHFFFAOYSA-N N-(4-butylphenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound C1=CC(CCCC)=CC=C1NC(=O)C(CS1)N(C)C1=NC1CCCCCC1 AKGQDKLGLYWYLP-UHFFFAOYSA-N 0.000 description 1
- ZHQFWGXTVLLJCX-UHFFFAOYSA-N N-(4-butylphenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.C1=CC(CCCC)=CC=C1NC(=O)C(CS1)N(C)C1=NC1CCCCCC1 ZHQFWGXTVLLJCX-UHFFFAOYSA-N 0.000 description 1
- JXFDSTDIDSPQTR-UHFFFAOYSA-N N-(4-chlorophenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C=CC(Cl)=CC=2)CSC1=NC1CCCCCC1 JXFDSTDIDSPQTR-UHFFFAOYSA-N 0.000 description 1
- UEYLPYGWFRFBRV-UHFFFAOYSA-N N-(4-chlorophenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.CN1C(C(=O)NC=2C=CC(Cl)=CC=2)CSC1=NC1CCCCCC1 UEYLPYGWFRFBRV-UHFFFAOYSA-N 0.000 description 1
- WXLWOEZXFXHALV-UHFFFAOYSA-N N-(4-tert-butylphenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C=CC(=CC=2)C(C)(C)C)CSC1=NC1CCCCCC1 WXLWOEZXFXHALV-UHFFFAOYSA-N 0.000 description 1
- QIKKONBKBJCHDL-UHFFFAOYSA-N N-(4-tert-butylphenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.CN1C(C(=O)NC=2C=CC(=CC=2)C(C)(C)C)CSC1=NC1CCCCCC1 QIKKONBKBJCHDL-UHFFFAOYSA-N 0.000 description 1
- ZXPMGCRCFAYNBM-UHFFFAOYSA-N N-(5-chloro-2-fluorophenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NC=2C(=CC=C(Cl)C=2)F)CSC1=NC1CCCCCC1 ZXPMGCRCFAYNBM-UHFFFAOYSA-N 0.000 description 1
- AJXNYPRKZHTKHX-UHFFFAOYSA-N N-(5-chloro-2-fluorophenyl)-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.CN1C(C(=O)NC=2C(=CC=C(Cl)C=2)F)CSC1=NC1CCCCCC1 AJXNYPRKZHTKHX-UHFFFAOYSA-N 0.000 description 1
- 108090000699 N-Type Calcium Channels Proteins 0.000 description 1
- 102000004129 N-Type Calcium Channels Human genes 0.000 description 1
- VCUANKFXMAAXMK-UHFFFAOYSA-N N-[(3-bromophenyl)methyl]-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide Chemical compound CN1C(C(=O)NCC=2C=C(Br)C=CC=2)CSC1=NC1CCCCCC1 VCUANKFXMAAXMK-UHFFFAOYSA-N 0.000 description 1
- HAKRTNRJRXGWEC-UHFFFAOYSA-N N-[(3-bromophenyl)methyl]-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.CN1C(C(=O)NCC=2C=C(Br)C=CC=2)CSC1=NC1CCCCCC1 HAKRTNRJRXGWEC-UHFFFAOYSA-N 0.000 description 1
- QTJAROBKKYUJTK-UHFFFAOYSA-N N-[(3-chlorophenyl)methyl]-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NCC=2C=C(Cl)C=CC=2)CSC1=NC1CCCCCC1 QTJAROBKKYUJTK-UHFFFAOYSA-N 0.000 description 1
- ZPGWRLYRKZFSRX-UHFFFAOYSA-N N-[(4-chlorophenyl)methyl]-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NCC=2C=CC(Cl)=CC=2)CSC1=NC1CCCCCC1 ZPGWRLYRKZFSRX-UHFFFAOYSA-N 0.000 description 1
- PULMVXYJYMTRBH-UHFFFAOYSA-N N-[3,5-bis(trifluoromethyl)phenyl]-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrobromide Chemical compound Br.CN1C(C(=O)NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)CSC1=NC1CCCCCC1 PULMVXYJYMTRBH-UHFFFAOYSA-N 0.000 description 1
- AXSKBUXVHXUNMC-UHFFFAOYSA-N N-[3,5-bis(trifluoromethyl)phenyl]-2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-carboxamide hydrochloride Chemical compound Cl.CN1C(C(=O)NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)CSC1=NC1CCCCCC1 AXSKBUXVHXUNMC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 108700012358 P/Q-type calcium channel Proteins 0.000 description 1
- 102000050761 P/Q-type calcium channel Human genes 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010034759 Petit mal epilepsy Diseases 0.000 description 1
- 102100033024 Voltage-dependent T-type calcium channel subunit alpha-1G Human genes 0.000 description 1
- 102100025482 Voltage-dependent T-type calcium channel subunit alpha-1H Human genes 0.000 description 1
- 102100025484 Voltage-dependent T-type calcium channel subunit alpha-1I Human genes 0.000 description 1
- 208000028311 absence seizure Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940125400 channel inhibitor Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- SKXVUXUQTLBCFE-UHFFFAOYSA-N cycloheptylmethylthiourea Chemical compound NC(=S)NCC1CCCCCC1 SKXVUXUQTLBCFE-UHFFFAOYSA-N 0.000 description 1
- RXSMRVGJBZWEAN-UHFFFAOYSA-N cycloheptylmethylurea Chemical compound NC(=O)NCC1CCCCCC1 RXSMRVGJBZWEAN-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000008406 drug-drug interaction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000003372 electrophysiological method Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- HAPOVYFOVVWLRS-UHFFFAOYSA-N ethosuximide Chemical compound CCC1(C)CC(=O)NC1=O HAPOVYFOVVWLRS-UHFFFAOYSA-N 0.000 description 1
- OHLRLMWUFVDREV-UHFFFAOYSA-N ethyl 4-chloro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CCl OHLRLMWUFVDREV-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HCBQTGAZENNMLM-UHFFFAOYSA-N methyl 4-bromo-3-oxopentanoate Chemical compound COC(=O)CC(=O)C(C)Br HCBQTGAZENNMLM-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- UHAAFJWANJYDIS-UHFFFAOYSA-N n,n'-diethylmethanediimine Chemical compound CCN=C=NCC UHAAFJWANJYDIS-UHFFFAOYSA-N 0.000 description 1
- LBBGJTMIMDDXMH-UHFFFAOYSA-N n-(1,3-benzodioxol-5-yl)-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=C3OCOC3=CC=2)CSC1=NC1CCCCC1 LBBGJTMIMDDXMH-UHFFFAOYSA-N 0.000 description 1
- RWTIELMSVWUEGW-UHFFFAOYSA-N n-(2-chloro-4-fluorophenyl)-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1Cl RWTIELMSVWUEGW-UHFFFAOYSA-N 0.000 description 1
- IAXXVSFZGDADTL-UHFFFAOYSA-N n-(2-chloro-4-fluorophenyl)-2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1Cl IAXXVSFZGDADTL-UHFFFAOYSA-N 0.000 description 1
- STMXRLLMEVMQNN-UHFFFAOYSA-N n-(2-chloro-4-fluorophenyl)-2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=C(F)C=C1Cl STMXRLLMEVMQNN-UHFFFAOYSA-N 0.000 description 1
- WUVCJTDNYWWYOI-UHFFFAOYSA-N n-(2-chloro-4-methylphenyl)-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(C)C=C1Cl WUVCJTDNYWWYOI-UHFFFAOYSA-N 0.000 description 1
- DLHDNHFPSQJBCI-UHFFFAOYSA-N n-(2-chloro-4-methylphenyl)-2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NC1=CC=C(C)C=C1Cl DLHDNHFPSQJBCI-UHFFFAOYSA-N 0.000 description 1
- NXGNIVMAPSSUJI-UHFFFAOYSA-N n-(2-chloro-4-methylphenyl)-2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC=C(C)C=C1Cl NXGNIVMAPSSUJI-UHFFFAOYSA-N 0.000 description 1
- WEUNCJSJOTXNBZ-UHFFFAOYSA-N n-(2-chloro-4-methylphenyl)-2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=C(C)C=C1Cl WEUNCJSJOTXNBZ-UHFFFAOYSA-N 0.000 description 1
- UNMZPAIMEFTEBY-UHFFFAOYSA-N n-(2-fluoro-5-nitrophenyl)-2-[3-methyl-2-(2-phenylethylimino)-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NCCC=2C=CC=CC=2)N(C)C1CC(=O)NC1=CC([N+]([O-])=O)=CC=C1F UNMZPAIMEFTEBY-UHFFFAOYSA-N 0.000 description 1
- LTRWKZFRAZMNMT-UHFFFAOYSA-N n-(3-chloro-4-methoxyphenyl)-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=C(Cl)C(OC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCCC1 LTRWKZFRAZMNMT-UHFFFAOYSA-N 0.000 description 1
- ZHDHUXFALXTPAS-UHFFFAOYSA-N n-(3-chloro-4-methylphenyl)-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(C)C(Cl)=C1 ZHDHUXFALXTPAS-UHFFFAOYSA-N 0.000 description 1
- MTZKTYHKQFZWQJ-UHFFFAOYSA-N n-(3-chloro-4-methylphenyl)-2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC=C(C)C(Cl)=C1 MTZKTYHKQFZWQJ-UHFFFAOYSA-N 0.000 description 1
- ZFPKTTRVFRXVCM-UHFFFAOYSA-N n-(3-chloro-4-methylphenyl)-2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=C(Cl)C(C)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 ZFPKTTRVFRXVCM-UHFFFAOYSA-N 0.000 description 1
- NANAJNXACYJCLV-UHFFFAOYSA-N n-(4-aminophenyl)-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(N)C=C1 NANAJNXACYJCLV-UHFFFAOYSA-N 0.000 description 1
- SMKZCXGVPSMXME-UHFFFAOYSA-N n-(4-bromo-3-methylphenyl)-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(Br)C(C)=C1 SMKZCXGVPSMXME-UHFFFAOYSA-N 0.000 description 1
- VQKLUYPNJQPZDZ-UHFFFAOYSA-N n-(4-bromophenyl)-2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide Chemical compound CN1C(CC(=O)NC=2C=CC(Br)=CC=2)C(C)SC1=NC1CCCCCC1 VQKLUYPNJQPZDZ-UHFFFAOYSA-N 0.000 description 1
- UXYSDTWKTWWMEB-UHFFFAOYSA-N n-(4-bromophenyl)-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(Br)C=C1 UXYSDTWKTWWMEB-UHFFFAOYSA-N 0.000 description 1
- CUPJGRFRWRLKOR-UHFFFAOYSA-N n-(4-bromophenyl)-2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide Chemical compound CN1C(CC(=O)NC=2C=CC(Br)=CC=2)C(C)SC1=NC1CCCCC1 CUPJGRFRWRLKOR-UHFFFAOYSA-N 0.000 description 1
- FVAWDSSDRJYCCB-UHFFFAOYSA-N n-(4-bromophenyl)-2-(2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(Br)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1CCCCC1 FVAWDSSDRJYCCB-UHFFFAOYSA-N 0.000 description 1
- MTQWOSFYYFBUFS-UHFFFAOYSA-N n-(4-bromophenyl)-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(Br)C=C1 MTQWOSFYYFBUFS-UHFFFAOYSA-N 0.000 description 1
- WNDKWGVZXMTPCZ-UHFFFAOYSA-N n-(4-bromophenyl)-2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC=C(Br)C=C1 WNDKWGVZXMTPCZ-UHFFFAOYSA-N 0.000 description 1
- AVIBUGWARLIQNW-UHFFFAOYSA-N n-(4-bromophenyl)-2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=C(Br)C=C1 AVIBUGWARLIQNW-UHFFFAOYSA-N 0.000 description 1
- SYJZCQHRZKUKOD-UHFFFAOYSA-N n-(4-bromophenyl)-2-(3-butyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCCC)C1CC(=O)NC1=CC=C(Br)C=C1 SYJZCQHRZKUKOD-UHFFFAOYSA-N 0.000 description 1
- XLISZOSBMPYVDI-UHFFFAOYSA-N n-(4-butylphenyl)-2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(C(C)S1)N(C)C1=NC1CCCCCC1 XLISZOSBMPYVDI-UHFFFAOYSA-N 0.000 description 1
- TULARUXOAGLVQB-UHFFFAOYSA-N n-(4-butylphenyl)-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCCCC1 TULARUXOAGLVQB-UHFFFAOYSA-N 0.000 description 1
- QXTZQVLOFDYEMT-UHFFFAOYSA-N n-(4-butylphenyl)-2-(2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1CCCCC1 QXTZQVLOFDYEMT-UHFFFAOYSA-N 0.000 description 1
- BBURWLQKFVQXHT-UHFFFAOYSA-N n-(4-butylphenyl)-2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(CC)C1=NC1CCCCC1 BBURWLQKFVQXHT-UHFFFAOYSA-N 0.000 description 1
- VUAUVSQDOVUIGU-UHFFFAOYSA-N n-(4-butylphenyl)-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCCC1 VUAUVSQDOVUIGU-UHFFFAOYSA-N 0.000 description 1
- VMWVDNZSOVTHPG-UHFFFAOYSA-N n-(4-butylphenyl)-2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(CCC)C1=NC1CCCCC1 VMWVDNZSOVTHPG-UHFFFAOYSA-N 0.000 description 1
- WIPWAJAHFDISAU-UHFFFAOYSA-N n-(4-butylphenyl)-2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CCCC1 WIPWAJAHFDISAU-UHFFFAOYSA-N 0.000 description 1
- MMHSXRQUKKIIIS-UHFFFAOYSA-N n-(4-butylphenyl)-2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(CCCC)=CC=C1NC(=O)CC(CS1)N(C)C1=NC1CC1 MMHSXRQUKKIIIS-UHFFFAOYSA-N 0.000 description 1
- PTDPHQVFZWEWAP-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F PTDPHQVFZWEWAP-UHFFFAOYSA-N 0.000 description 1
- SIRTYMOOSBIFLE-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F SIRTYMOOSBIFLE-UHFFFAOYSA-N 0.000 description 1
- BUUPSYMYASZLPD-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F BUUPSYMYASZLPD-UHFFFAOYSA-N 0.000 description 1
- BAWLYCFIDZAQQP-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F BAWLYCFIDZAQQP-UHFFFAOYSA-N 0.000 description 1
- VQEDGXUYOAFLBU-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-[2-(3-fluorophenyl)imino-3-methyl-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=C(F)C=CC=2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F VQEDGXUYOAFLBU-UHFFFAOYSA-N 0.000 description 1
- VDKMBYUGFUDMFM-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-[2-(4-chlorophenyl)imino-3-methyl-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=CC(Cl)=CC=2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F VDKMBYUGFUDMFM-UHFFFAOYSA-N 0.000 description 1
- ZYYPGHLUJKHDIZ-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-[2-(4-cyanophenyl)imino-3-methyl-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=CC(=CC=2)C#N)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F ZYYPGHLUJKHDIZ-UHFFFAOYSA-N 0.000 description 1
- KXTXOIPSIRQFIT-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-[2-(4-ethylphenyl)imino-3-methyl-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1N=C1N(C)C(CC(=O)NC=2C(=CC(Cl)=CC=2)F)CS1 KXTXOIPSIRQFIT-UHFFFAOYSA-N 0.000 description 1
- RCHZIIYMEAFNLF-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-[3-methyl-2-(4-methylphenyl)imino-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=CC(C)=CC=2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F RCHZIIYMEAFNLF-UHFFFAOYSA-N 0.000 description 1
- PDOTYBMSLXEHHL-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-[3-methyl-2-(4-phenylphenyl)imino-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=CC(=CC=2)C=2C=CC=CC=2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F PDOTYBMSLXEHHL-UHFFFAOYSA-N 0.000 description 1
- QWSJLMJMIWBSQJ-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-[3-methyl-2-(4-propan-2-ylphenyl)imino-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1N=C1N(C)C(CC(=O)NC=2C(=CC(Cl)=CC=2)F)CS1 QWSJLMJMIWBSQJ-UHFFFAOYSA-N 0.000 description 1
- PTUTVRVJWOYAQY-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-[3-methyl-2-[4-(trifluoromethoxy)phenyl]imino-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=CC(OC(F)(F)F)=CC=2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F PTUTVRVJWOYAQY-UHFFFAOYSA-N 0.000 description 1
- BSQHMLXBQZYCPM-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-2-[3-methyl-2-[4-(trifluoromethyl)phenyl]imino-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=CC(=CC=2)C(F)(F)F)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1F BSQHMLXBQZYCPM-UHFFFAOYSA-N 0.000 description 1
- BFUFWNIDICOIOJ-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(Cl)=CC=2)C(C)SC1=NC1CCCCCC1 BFUFWNIDICOIOJ-UHFFFAOYSA-N 0.000 description 1
- WRTJTFCISPZQDK-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 WRTJTFCISPZQDK-UHFFFAOYSA-N 0.000 description 1
- HOUHFXSEZDDQBA-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide Chemical compound CN1C(CC(=O)NC=2C=CC(Cl)=CC=2)C(C)SC1=NC1CCCCC1 HOUHFXSEZDDQBA-UHFFFAOYSA-N 0.000 description 1
- WBHHAQLEGQIPON-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NC1=CC=C(Cl)C=C1 WBHHAQLEGQIPON-UHFFFAOYSA-N 0.000 description 1
- ZWDOGPUYKDZRQP-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 ZWDOGPUYKDZRQP-UHFFFAOYSA-N 0.000 description 1
- DXEZWDXQWHXHEH-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC=C(Cl)C=C1 DXEZWDXQWHXHEH-UHFFFAOYSA-N 0.000 description 1
- ONHUFFBPAVNTII-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(Cl)=CC=2)C(C)SC1=NC1CCCC1 ONHUFFBPAVNTII-UHFFFAOYSA-N 0.000 description 1
- ZGQODZJCUODIAR-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 ZGQODZJCUODIAR-UHFFFAOYSA-N 0.000 description 1
- NVDLPFHKIXTMST-UHFFFAOYSA-N n-(4-chlorophenyl)-2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 NVDLPFHKIXTMST-UHFFFAOYSA-N 0.000 description 1
- XJVQXJZHXSSKLJ-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[2-(3-methoxyphenyl)imino-3-methyl-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.COC1=CC=CC(N=C2N(C(CC(=O)NC=3C=CC(Cl)=CC=3)CS2)C)=C1 XJVQXJZHXSSKLJ-UHFFFAOYSA-N 0.000 description 1
- HFSNTJLMGSQBTK-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[2-(4-chlorophenyl)imino-3-methyl-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=CC(Cl)=CC=2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 HFSNTJLMGSQBTK-UHFFFAOYSA-N 0.000 description 1
- KINAPJSWKURZAV-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[2-(4-methoxyphenyl)imino-3-methyl-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1N=C1N(C)C(CC(=O)NC=2C=CC(Cl)=CC=2)CS1 KINAPJSWKURZAV-UHFFFAOYSA-N 0.000 description 1
- ULVAUBMHGYIZPX-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[2-(cyclohexylmethylimino)-3-methyl-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NCC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 ULVAUBMHGYIZPX-UHFFFAOYSA-N 0.000 description 1
- CGABGQVSGOCGTF-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[3-methyl-2-(2-phenylethylimino)-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NCCC=2C=CC=CC=2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 CGABGQVSGOCGTF-UHFFFAOYSA-N 0.000 description 1
- HYDNACGNMMQNTR-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[3-methyl-2-(3-nitrophenyl)imino-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=C(C=CC=2)[N+]([O-])=O)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 HYDNACGNMMQNTR-UHFFFAOYSA-N 0.000 description 1
- RHXPYXYGZKBPEX-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[3-methyl-2-(3-propan-2-yloxyphenyl)imino-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.CC(C)OC1=CC=CC(N=C2N(C(CC(=O)NC=3C=CC(Cl)=CC=3)CS2)C)=C1 RHXPYXYGZKBPEX-UHFFFAOYSA-N 0.000 description 1
- JLAFECPDNRHHED-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[3-methyl-2-(4-phenoxyphenyl)imino-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NC=2C=CC(OC=3C=CC=CC=3)=CC=2)N(C)C1CC(=O)NC1=CC=C(Cl)C=C1 JLAFECPDNRHHED-UHFFFAOYSA-N 0.000 description 1
- ZEUYBWKADJIZPO-UHFFFAOYSA-N n-(4-tert-butylphenyl)-2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(=CC=2)C(C)(C)C)C(C)SC1=NC1CCCCCC1 ZEUYBWKADJIZPO-UHFFFAOYSA-N 0.000 description 1
- KGNFWPXBINUDNH-UHFFFAOYSA-N n-(4-tert-butylphenyl)-2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(=CC=2)C(C)(C)C)C(C)SC1=NC1CCCCC1 KGNFWPXBINUDNH-UHFFFAOYSA-N 0.000 description 1
- UNAFUNXTQAYXCG-UHFFFAOYSA-N n-(4-tert-butylphenyl)-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NC1=CC=C(C(C)(C)C)C=C1 UNAFUNXTQAYXCG-UHFFFAOYSA-N 0.000 description 1
- BRYCPLJMLHEVMO-UHFFFAOYSA-N n-(4-tert-butylphenyl)-2-(2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=CC(=CC=2)C(C)(C)C)C(C)SC1=NC1CCCC1 BRYCPLJMLHEVMO-UHFFFAOYSA-N 0.000 description 1
- OEVHQEWFKMQELV-UHFFFAOYSA-N n-(4-tert-butylphenyl)-2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(C(C)(C)C)=CC=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 OEVHQEWFKMQELV-UHFFFAOYSA-N 0.000 description 1
- MLOZEHPMHMXOJE-UHFFFAOYSA-N n-(5-chloro-2-fluorophenyl)-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC(Cl)=CC=C1F MLOZEHPMHMXOJE-UHFFFAOYSA-N 0.000 description 1
- ZRRDWTSORUMEHZ-UHFFFAOYSA-N n-(5-chloro-2-fluorophenyl)-2-(2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.FC1=CC=C(Cl)C=C1NC(=O)CC(CS1)N(C2CC2)C1=NC1CCCCC1 ZRRDWTSORUMEHZ-UHFFFAOYSA-N 0.000 description 1
- IZYATJWJZOVRHX-UHFFFAOYSA-N n-(5-chloro-2-fluorophenyl)-2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC(Cl)=CC=C1F IZYATJWJZOVRHX-UHFFFAOYSA-N 0.000 description 1
- OYFJWMGAMLBYKU-UHFFFAOYSA-N n-(5-chloro-2-fluorophenyl)-2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC(Cl)=CC=C1F OYFJWMGAMLBYKU-UHFFFAOYSA-N 0.000 description 1
- ZERXUEWIWWAVJI-UHFFFAOYSA-N n-(5-chloro-2-fluorophenyl)-2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.FC1=CC=C(Cl)C=C1NC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 ZERXUEWIWWAVJI-UHFFFAOYSA-N 0.000 description 1
- LOYONGXTRUKBDU-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NCC1=CC=C(Cl)C=C1 LOYONGXTRUKBDU-UHFFFAOYSA-N 0.000 description 1
- FOHISDSMPPUNOL-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NCC1=CC=C(Cl)C=C1 FOHISDSMPPUNOL-UHFFFAOYSA-N 0.000 description 1
- YLHZPCDDPAOUNM-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NCC1=CC=C(Cl)C=C1 YLHZPCDDPAOUNM-UHFFFAOYSA-N 0.000 description 1
- DMICVHOMHFRRJG-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NCC1=CC=C(Cl)C=C1 DMICVHOMHFRRJG-UHFFFAOYSA-N 0.000 description 1
- SOAAFDUZJYCQMM-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-2-(3-cyclohexyl-2-cyclohexylimino-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1CNC(=O)CC(CS1)N(C2CCCCC2)C1=NC1CCCCC1 SOAAFDUZJYCQMM-UHFFFAOYSA-N 0.000 description 1
- QTJQZVYQJOFQLV-UHFFFAOYSA-N n-[3,5-bis(fluoromethyl)phenyl]-2-(2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=C(CF)C=C(CF)C=2)C(C)SC1=NC1CCCCC1 QTJQZVYQJOFQLV-UHFFFAOYSA-N 0.000 description 1
- OZSGECZMVOMAOD-UHFFFAOYSA-N n-[3,5-bis(trifluoromethyl)phenyl]-2-(2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.CN1C(CC(=O)NC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)C(C)SC1=NC1CCCCCC1 OZSGECZMVOMAOD-UHFFFAOYSA-N 0.000 description 1
- DDQSKGSAQGXVIA-UHFFFAOYSA-N n-[3,5-bis(trifluoromethyl)phenyl]-2-(2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC(C(F)(F)F)=CC(NC(=O)CC2N(C(=NC3CCCCC3)SC2)C2CC2)=C1 DDQSKGSAQGXVIA-UHFFFAOYSA-N 0.000 description 1
- PQHNIHZCCKRGBU-UHFFFAOYSA-N n-[3,5-bis(trifluoromethyl)phenyl]-2-(2-cyclohexylimino-3-ethyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CC)C1CC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 PQHNIHZCCKRGBU-UHFFFAOYSA-N 0.000 description 1
- UCLJHSILGRCOSQ-UHFFFAOYSA-N n-[3,5-bis(trifluoromethyl)phenyl]-2-(2-cyclohexylimino-3-propyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(CCC)C1CC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 UCLJHSILGRCOSQ-UHFFFAOYSA-N 0.000 description 1
- KVETYNSGVSNGBC-UHFFFAOYSA-N n-[3,5-bis(trifluoromethyl)phenyl]-2-[2-(cyclohexylmethylimino)-3-methyl-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NCC2CCCCC2)N(C)C1CC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 KVETYNSGVSNGBC-UHFFFAOYSA-N 0.000 description 1
- ZZYHPSZCHTZOLQ-UHFFFAOYSA-N n-[3,5-bis(trifluoromethyl)phenyl]-2-[3-methyl-2-(2-phenylethylimino)-1,3-thiazolidin-4-yl]acetamide;hydrochloride Chemical compound Cl.C1SC(=NCCC=2C=CC=CC=2)N(C)C1CC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 ZZYHPSZCHTZOLQ-UHFFFAOYSA-N 0.000 description 1
- KBXKIIJOEPRFRI-UHFFFAOYSA-N n-[4-(cyanomethyl)phenyl]-2-(2-cycloheptylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCCC2)N(C)C1CC(=O)NC1=CC=C(CC#N)C=C1 KBXKIIJOEPRFRI-UHFFFAOYSA-N 0.000 description 1
- VVZJSGPCYFLODP-UHFFFAOYSA-N n-[4-(cyanomethyl)phenyl]-2-(2-cyclopentylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCC2)N(C)C1CC(=O)NC1=CC=C(CC#N)C=C1 VVZJSGPCYFLODP-UHFFFAOYSA-N 0.000 description 1
- QHXCPRYONAGFMZ-UHFFFAOYSA-N n-[4-(cyanomethyl)phenyl]-2-(2-cyclopropylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CC2)N(C)C1CC(=O)NC1=CC=C(CC#N)C=C1 QHXCPRYONAGFMZ-UHFFFAOYSA-N 0.000 description 1
- JVFTWZCZIWZZAE-UHFFFAOYSA-N n-benzyl-2-(2-cyclohexylimino-3-methyl-1,3-thiazolidin-4-yl)acetamide;hydrochloride Chemical compound Cl.C1SC(=NC2CCCCC2)N(C)C1CC(=O)NCC1=CC=CC=C1 JVFTWZCZIWZZAE-UHFFFAOYSA-N 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000021264 seasoned food Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (11)
- 아래의 화학식 I의 구조를 갖는 화합물:[화학식 I]상기 식 중,R1은 수소 또는 C1-C5의 직쇄 또는 측쇄 알킬이고R2, R3 및 R4는 서로 동일하거나 상이한 것으로, 각각 수소 원자, 할로겐 원자, C1-C5의 직쇄 또는 측쇄 알킬, C1-C5의 알킬옥시, 트리플루오르메틸, 트리플루오르메톡시, 페닐옥시, 아미노, 메탄설폰아미노, 파라톨루엔설폰아미노, 니트로, C1-C5의 시아노알킬, 시아노, 에톡시카르보닐 및 C3-C12의 시클로알킬로 이루어진 군 중에서 각각 선택된 것이며,R5는 C1-C5의 직쇄 또는 측쇄 알킬기, C3-C6의 사이클로알킬, 및 벤질기로 이루어진 군 중에서 선택된 것이며R6는 C3-C12 사이클로알킬, C4-C17 알킬사이클로알킬, 아다만틸, 벤질 및 C8-C13의 벤질알킬로 이루어진 군 중에서 선택된 것이고,n 및 m 은 각각 0 또는 1 이며,HX는 존재하거나 존재하지 않을 수 있고,HX가 존재하면 X는 할로겐 원자이다.
- 제1항에 있어서,상기 R5는 메틸, 에틸, 직쇄 또는 측쇄 프로필, 직쇄 또는 측쇄 부틸, 사이클로프로필, 사이클로헥실, 및 벤질로 이루어진 군 중에서 선택된 것인 화합물.
- 제1항에 있어서,상기 R6는 사이클로펜틸, 사이클로헥실, 사이클로헵틸, 메틸-사이클로헥실, 1-아다만틸, 2-아다만틸, 및 펜에틸로 이루어진 군 중에서 선택된 것인 화합물.
- 제1항에 있어서,상기 R2, R3, 및 R4 은 서로 동일하거나 상이한 것으로, 각각 수소 원자, 할로겐 원자, 메틸, 에틸, 직쇄 또는 측쇄 프로필, 직쇄 또는 측쇄 부틸, 메톡시, 트리플루오르메틸, 트리플루오르메톡시, 페닐옥시, 아미노, 메탄설폰아미노, 파라톨루엔설폰아미노, 니트로, 시아노메틸, 시아노, 에톡시카르보닐 및 사이클로펩틸로 이루어진 군 중에서 각 선택된 화합물.
- 제1항에 있어서,상기 R1은 수소 또는 메틸인 화합물.
- 삭제
- 제1항 내지 제6항 중 어느 한 항에 따른 화합물을 유효성분으로 함유하는,통증, 간질, 고혈압, 협심증, 부정맥, 및 암으로 이루어진 군 중에서 선택된 한 가지 이상의 질병의 치료 또는 예방용 조성물.
- 제1항 내지 제6항 중 어느 한 항에 따른 화합물을 함유하는, 통증, 간질, 고혈압, 협심증, 부정맥, 및 암으로 이루어진 군 중에서 선택된 한 가지 이상의 질병의 개선 또는 예방용 건강보조식품.
- 아래의 화학식 II의 화합물과 화학식 III의 화합물을 C1 내지 C5의 알코올 용액 중에서 5 내지 20시간 동안 20 내지 130 ℃에서 가열 환류시켜 아래의 화학식 IV의 화합물을 제조하는 단계;상기 제조된 화학식 IV의 화합물에 염기성 수용액을 넣어 30분 내지 5시간 동안 20 내지 120 ℃에서 가열 환류시키고, 할로겐화수소산을 첨가하여 pH를 1 내지 4로 조절하여 화학식 V의 화합물을 제조하는 단계; 및상기 얻어진 화학식 V의 화합물에 화학식 VI의 화합물과 아마이드 축합결합제를 넣고 반응시켜 화학식 I의 화합물을 얻는 단계를 포함하는 화학식 I의 화합물의 제조 방법:[화학식 I][화학식 II][화학식 III][화학식 IV][화학식 V][화학식 VI]상기 식 중,R1은 수소, 또는 C1-C5의 직쇄 또는 측쇄 알킬이고R2, R3 및 R4 는 서로 동일하거나 상이한 것으로, 각각 수소 원자, 할로겐 원자, C1-C5의 직쇄 또는 측쇄 알킬, C1-C5의 알킬옥시, 트리플루오르메틸, 트리플루오르메톡시, 페닐옥시, 아미노, 메탄설폰아미노, 파라톨루엔설폰아미노, 니트로, C1-C5의 시아노알킬, 시아노, 에톡시카르보닐 및 C3-C12의 시클로알킬로 이루어진 군 중에서 각각 선택된 것이며,R5는 C1-C5의 직쇄 또는 측쇄 알킬기, C3-C6의 사이클로알킬, 및 벤질기로 이루어진 군 중에서 선택된 것이며R6는 C3-C12 사이클로알킬, C4-C17 알킬사이클로알킬, 아다만틸, 벤질 및 C8-C13의 벤질알킬로 이루어진 군 중에서 선택된 것이고,R7은 C1-C6의 알콕시이며,n 및 m 은 각각 0 또는 1 이고,X와 Y는 서로 동일하거나 상이한 것으로 각각 독립적으로 플루오르, 염소, 브롬 및 요오드로 이루어진 군 중에서 선택된 할로겐 원자이며HX는 존재하거나 존재하지 않을 수 있다.
- 아래의 화학식 VII의 화합물과 화학식 VIII의 화합물을 C1 내지 C5의 알코올 용액중에서 5 내지 25시간 20 내지 130 ℃에서 가열 환류시키고 직접 반응시켜, 화학식 I의 화합물을 제조하는 단계를 포함하는,화학식 I의 화합물의 제조 방법:[화학식 I][화학식 VII][화학식 VIII]상기 식 중,R1은 수소, 또는 C1-C5의 직쇄 또는 측쇄 알킬이고R2, R3 및 R4 는 서로 동일하거나 상이한 것으로, 각각 수소 원자, 할로겐 원자, C1-C5의 직쇄 또는 측쇄 알킬, C1-C5의 알킬옥시, 트리플루오르메틸, 트리플루오르메톡시, 페닐옥시, 아미노, 메탄설폰아미노, 파라톨루엔설폰아미노, 니트로, C1-C5의 시아노알킬, 시아노, 에톡시카르보닐 및 C3-C12의 시클로알킬로 이루어진 군 중에서 각각 선택된 것이며,R5는 C1-C5의 직쇄 또는 측쇄 알킬기, C3-C6의 사이클로알킬, 및 벤질기로 이루어진 군 중에서 선택된 것이며R6는 C3-C12 사이클로알킬, C4-C17 알킬사이클로알킬, 아다만틸, 벤질 및 C8-C13의 벤질알킬로 이루어진 군 중에서 선택된 것이고,n 및 m 은 각각 0 또는 1 이며,Y는 플루오르, 염소, 브롬 및 요오드로 이루어진 군 중에서 선택된 할로겐 원자이고,HX는 존재하거나 존재하지 않을 수 있고,HX가 존재하면 X는 할로겐 원자이다.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070050185A KR100863239B1 (ko) | 2007-05-23 | 2007-05-23 | 신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는t-형 칼슘 채널 저해제 |
US12/124,737 US7998989B2 (en) | 2007-05-23 | 2008-05-21 | 2-Imino-1,3-thiazoline-based compounds and T-type calcium channel inhibitors containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070050185A KR100863239B1 (ko) | 2007-05-23 | 2007-05-23 | 신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는t-형 칼슘 채널 저해제 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100863239B1 true KR100863239B1 (ko) | 2008-10-15 |
Family
ID=40072986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070050185A Expired - Fee Related KR100863239B1 (ko) | 2007-05-23 | 2007-05-23 | 신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는t-형 칼슘 채널 저해제 |
Country Status (2)
Country | Link |
---|---|
US (1) | US7998989B2 (ko) |
KR (1) | KR100863239B1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017070680A1 (en) | 2015-10-22 | 2017-04-27 | Cavion Llc | Methods for treating angelman syndrome and related disorders |
CN105831131B (zh) * | 2016-04-26 | 2018-07-17 | 南京华洲药业有限公司 | 一种含氟唑菌酰胺和噻菌灵的杀菌组合物及其应用 |
WO2018152317A1 (en) | 2017-02-15 | 2018-08-23 | Cavion, Inc. | Calcium channel inhibitors |
JP7321097B2 (ja) | 2017-04-26 | 2023-08-04 | カビオン・インコーポレイテッド | 記憶および認知を改善する、ならびに記憶および認知障害を処置するための方法 |
KR20210087459A (ko) | 2018-10-03 | 2021-07-12 | 카비온, 인코포레이티드 | (r)-2-(4-이소프로필페닐)-n-(1-(5-(2,2,2-트리플루오로에톡시)피리딘-2-일)에틸)아세트아미드를 사용하는 본태성 진전 치료 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001007424A1 (fr) * | 1999-07-22 | 2001-02-01 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | 2-arylimino-2,3-dihydrothiazoles et leur utilisation comme ligands des recepteurs de la somatostatine |
WO2002002542A1 (en) * | 2000-06-30 | 2002-01-10 | Sumitomo Pharmaceuticals Company, Limited | Five-membered-ring compound |
WO2002013611A1 (en) * | 2000-07-28 | 2002-02-21 | Korea Institute Of Science And Technology | 2-phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same |
WO2002055510A1 (fr) * | 2001-01-12 | 2002-07-18 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Derives de 2-arylimino-2,3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700583B2 (en) * | 2003-04-11 | 2010-04-20 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
-
2007
- 2007-05-23 KR KR1020070050185A patent/KR100863239B1/ko not_active Expired - Fee Related
-
2008
- 2008-05-21 US US12/124,737 patent/US7998989B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001007424A1 (fr) * | 1999-07-22 | 2001-02-01 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | 2-arylimino-2,3-dihydrothiazoles et leur utilisation comme ligands des recepteurs de la somatostatine |
WO2002002542A1 (en) * | 2000-06-30 | 2002-01-10 | Sumitomo Pharmaceuticals Company, Limited | Five-membered-ring compound |
WO2002013611A1 (en) * | 2000-07-28 | 2002-02-21 | Korea Institute Of Science And Technology | 2-phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same |
WO2002055510A1 (fr) * | 2001-01-12 | 2002-07-18 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Derives de 2-arylimino-2,3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique |
Also Published As
Publication number | Publication date |
---|---|
US7998989B2 (en) | 2011-08-16 |
US20080293786A1 (en) | 2008-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100589868B1 (ko) | 아미드유도체 | |
Murata et al. | Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors. Part 1 | |
EP1407774A1 (en) | 2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds | |
AU2005241073B2 (en) | Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme | |
JP4679517B2 (ja) | 薬剤としてのアゼピン誘導体 | |
KR100863239B1 (ko) | 신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는t-형 칼슘 채널 저해제 | |
JP2002531444A (ja) | ベンズアミド誘導体およびapoB‐100分泌阻害剤としてのそれらの使用 | |
JP2010280732A (ja) | Lxrのモジュレーター | |
WO2007137066A2 (en) | HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME | |
MD3765439T2 (ro) | Polimorfi noi ai sării de calciu ca agenti anti-inflamatori, imunomodulatori și anti-proliferatori | |
AU2005275279A1 (en) | Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases | |
NO301929B1 (no) | 4-aryl-tiazol- eller -imidazol-derivater | |
TWI235061B (en) | Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and pharmaceutical compositions containing same | |
KR100969686B1 (ko) | 신규한 티아졸계 화합물 및 이를 함유하는 t-형 칼슘 채널저해제 | |
EA014233B1 (ru) | Замещенные карбоксамиды | |
WO2006020680A2 (en) | Heterocyclic compounds as pharmaceutical agents | |
SK113199A3 (en) | Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions | |
WO2011037985A1 (en) | Aminothienopyridazine inhibitors of tau assembly | |
JPH10306024A (ja) | 糸球体疾患の予防および治療剤 | |
CN114831977B (zh) | 苯甲酸类衍生物作为trpm2蛋白抑制剂的用途 | |
Mohareb et al. | Use of 2-aminoprop-1-ene-1, 1, 3-tricarbonitrile for the synthesis of tetrahydronaphthalene, hexahydroisoquinoline and hexahydrocinnoline derivatives with potential antitumor activities | |
JP5944483B2 (ja) | アダマンチル基を有するスルファミド誘導体及びこれの薬剤学的に許容可能な塩 | |
US4287207A (en) | Pharmaceutical composition containing 1,3,5-substituted biuret compound | |
DE10356717A1 (de) | Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten | |
KR101049935B1 (ko) | 신규한 티아졸린계 화합물 및 이를 포함하는 t-형 칼슘 채널 저해제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20070523 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20080428 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20080924 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20081007 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20081008 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20110930 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20110930 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20120731 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20120731 Start annual number: 5 End annual number: 6 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20150909 |